Showing results (1981-1990 of 2,420) with videos related to

Sort By:
Pageof 242
Journal of the American Heart Association|July 9, 2021
Treatment Inertia in Patients With Familial HypercholesterolemiaAnatoly Langer, G B John Mancini, Mary Tan, et al.
Journal of Personality and Social Psychology|July 9, 1998
A comparison of coping assessed by ecological momentary assessment and retrospective recallA A Stone, J E Schwartz, J M Neale, et al.
Journal of Vascular Surgery|September 5, 2006
Duplex ultrasound criteria for femorofemoral bypass revisionPatrick A Stone, Paul A Armstrong, Dennis F Bandyk, et al.
The Ocular Surface|June 9, 2018
A new scale for the assessment of conjunctival bulbar rednessIlaria Macchi, Vatinee Y Bunya, Mina Massaro-Giordano, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|October 27, 1999
Loss of differentiation of 4NQO-induced rat malignant oral keratinocytes correlates with metastatic dissemination and is associated with a reduced cellular response to TGF-beta1 and an altered receptor profileM Davies, I C Paterson, A Stone, et al.
The Journal of Surgical Research|June 19, 2007
MF-tricyclic inhibits growth of experimental abdominal aortic aneurysmsW Brent Keeling, Amy E Hackmann, Mary E Colter, et al.
International Journal of Cancer|February 1, 1994
TGF-beta receptor regulation mediates the response to exogenous ligand but is independent of the degree of cellular differentiation in human oral keratinocytesS S Prime, J B Matthews, V Patel, et al.
JAMA Ophthalmology|September 15, 2017
Development and Evaluation of Semiautomated Quantification of Lissamine Green Staining of the Bulbar Conjunctiva From Digital ImagesVatinee Y Bunya, Min Chen, Yuanjie Zheng, et al.
Genes and Immunity|May 14, 2010
Elucidating the chromosome 9 association with AS; CARD9 is a candidate geneJ J Pointon, D Harvey, T Karaderi, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 19, 2016
Model-Based Characterization of the Pharmacokinetics of Pembrolizumab: A Humanized Anti-PD-1 Monoclonal Antibody in Advanced Solid TumorsM Ahamadi, T Freshwater, M Prohn, et al.
Pageof 242